Articoli con mandati relativi all'accesso pubblico - Ollie ÖstlundUlteriori informazioni
Non disponibili pubblicamente: 4
Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial
P Andell, S James, O Östlund, T Yndigegn, D Sparv, J Pernow, T Jernberg, ...
European Heart Journal: Acute Cardiovascular Care 9 (8), 984-992, 2020
Mandati: Swedish Research Council
Oxygen therapy in myocardial infarction patients with or without diabetes: a predefined subgroup analysis from the DETO2X-AMI trial
T Nyström, SK James, B Lindahl, O Östlund, D Erlinge, J Herlitz, ...
Diabetes care 42 (11), 2032-2041, 2019
Mandati: Swedish Research Council
Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART
S Völz, O Angerås, S Koul, I Haraldsson, G Sarno, D Venetsanos, ...
European Heart Journal: Acute Cardiovascular Care 8 (6), 510-519, 2019
Mandati: Swedish Research Council
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
E Omerovic, S James, T Råmundal, O Fröbert, R Linder, M Danielewicz, ...
Cardiovascular Revascularization Medicine, 2024
Mandati: Swedish Research Council
Disponibili pubblicamente: 24
Thrombus aspiration during ST-segment elevation myocardial infarction
O Fröbert, B Lagerqvist, GK Olivecrona, E Omerovic, T Gudnason, ...
New England Journal of Medicine 369 (17), 1587-1597, 2013
Mandati: Swedish Research Council
Outcomes 1 year after thrombus aspiration for myocardial infarction
B Lagerqvist, O Fröbert, GK Olivecrona, T Gudnason, M Maeng, P Alström, ...
New England Journal of Medicine 371 (12), 1111-1120, 2014
Mandati: Swedish Research Council
Oxygen therapy in suspected acute myocardial infarction
R Hofmann, SK James, T Jernberg, B Lindahl, D Erlinge, N Witt, G Arefalk, ...
New England Journal of Medicine 377 (13), 1240-1249, 2017
Mandati: Swedish Research Council
Bivalirudin versus heparin monotherapy in myocardial infarction
D Erlinge, E Omerovic, O Fröbert, R Linder, M Danielewicz, M Hamid, ...
New England Journal of Medicine 377 (12), 1132-1142, 2017
Mandati: Swedish Research Council
Inflammatory biomarkers interleukin‐6 and C‐reactive protein and outcomes in stable coronary heart disease: experiences from the STABILITY (stabilization of atherosclerotic …
C Held, HD White, RAH Stewart, A Budaj, CP Cannon, JS Hochman, ...
Journal of the American Heart Association 6 (10), e005077, 2017
Mandati: US National Institutes of Health
Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease
D Lindholm, J Lindbäck, PW Armstrong, A Budaj, CP Cannon, ...
Journal of the American College of Cardiology 70 (7), 813-826, 2017
Mandati: US National Institutes of Health
Therapeutic hypothermia for the treatment of acute myocardial infarction–combined analysis of the RAPID MI-ICE and the CHILL-MI trials
D Erlinge, M Götberg, M Noc, I Lang, M Holzer, P Clemmensen, U Jensen, ...
Therapeutic hypothermia and temperature management 5 (2), 77-84, 2015
Mandati: Swedish Research Council
Beta-blockers after myocardial infarction and preserved ejection fraction
T Yndigegn, B Lindahl, K Mars, J Alfredsson, J Benatar, L Brandin, ...
New England Journal of Medicine 390 (15), 1372-1381, 2024
Mandati: Swedish Research Council
Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
L Wallentin, C Held, PW Armstrong, CP Cannon, RY Davies, CB Granger, ...
Journal of the American Heart Association 5 (6), e003407, 2016
Mandati: US National Institutes of Health, American Heart Association
Oxygen therapy in ST-elevation myocardial infarction
R Hofmann, N Witt, B Lagerqvist, T Jernberg, B Lindahl, D Erlinge, ...
European heart journal 39 (29), 2730-2739, 2018
Mandati: Swedish Research Council
Heterogeneity in blood pressure response to 4 antihypertensive drugs: a randomized clinical trial
J Sundström, L Lind, S Nowrouzi, E Hagström, C Held, P Lytsy, B Neal, ...
JAMA 329 (14), 1160-1169, 2023
Mandati: Swedish Research Council
Long-term effects of oxygen therapy on death or hospitalization for heart failure in patients with suspected acute myocardial infarction
T Jernberg, B Lindahl, J Alfredsson, E Berglund, O Bergström, A Engström, ...
Circulation 138 (24), 2754-2762, 2018
Mandati: Swedish Research Council
FFR-guided complete or culprit-only PCI in patients with myocardial infarction
F Böhm, B Mogensen, T Engstrøm, G Stankovic, I Srdanovic, J Lønborg, ...
New England Journal of Medicine 390 (16), 1481-1492, 2024
Mandati: Swedish Research Council
Effect of oxygen therapy on cardiovascular outcomes in relation to baseline oxygen saturation
SK James, D Erlinge, J Herlitz, J Alfredsson, S Koul, O Fröbert, T Kellerth, ...
Cardiovascular Interventions 13 (4), 502-513, 2020
Mandati: Swedish Research Council
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
T Yndigegn, B Lindahl, J Alfredsson, J Benatar, L Brandin, D Erlinge, ...
European Heart Journal-Cardiovascular Pharmacotherapy 9 (2), 192-197, 2023
Mandati: Swedish Research Council
Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction
S James, S Koul, J Andersson, O Angerås, P Bhiladvala, F Calais, ...
Circulation: Cardiovascular Interventions 14 (12), e008969, 2021
Mandati: Swedish Research Council
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software